Search

everythinglearnresearchcommunity

for

Search:↓

Erythematous papulopustular eruptions in cancer patients using EGFR inhibitors show specific skin changes that vary with severity and treatment type.

Mouse epidermal growth factor temporarily stops wool growth and causes cell changes in Merino sheep.

EGF and FGF can boost hair growth by speeding up cell growth.

EGFR inhibitors often cause dry, brittle hair and eyebrow/eyelash changes.

Jagged1 and Epidermal Growth Factor together significantly increased hair growth in mice with androgen-suppressed hair.

Epidermal growth factor disrupts hair and gland formation in bandicoots.

Normal skin results from interactions between EGF and the Tabby mutation.

Cetuximab often causes skin problems, but they can be managed without stopping treatment.

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

Too much epidermal growth factor can cause hair loss.

Topical EGF may cause unexpected hair growth during wound healing.

Epidermal growth factor reduces hair growth, but cortisol does not.

Mathematical modeling helps understand and predict the MAPK cell signaling pathway.

A new method quickly detects hair changes from EGFR inhibitors using a microscope.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

Inhibiting certain proteins harms hair follicle immunity and increases IL-33, affecting hair health.

Higher EGF levels are linked to more severe alopecia areata.

You might not need to stop cancer treatment if you get a rare skin reaction from EGFR inhibitors, as skin treatments can help manage it.

Lasers can help reduce skin side effects from cancer treatment.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

Blocking EGFR can lead to hair loss due to inflammation and stem cell damage.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

EGFR is crucial for preventing hair follicle inflammation and hair loss.

People with alopecia areata have higher levels of EGF in their blood than healthy people.

Certain gene variations might increase the risk of a hair loss condition in Koreans.

Epidermal growth factor helps hair regrow after chemotherapy.